*ST赛隆(002898.SZ)公告，公司全资子公司湖南赛隆药业有限公司于近日获得国家药品监督管理局核准 签发的门冬氨酸镁《化学原料药上市申请批准通知书》及门冬氨酸钾《化学原料药上市申请批准通知 书》。化学原料药门冬氨酸钾、门冬氨酸镁可用于生产门冬氨酸钾注射液、门冬氨酸钾镁注射液等制 剂，为电解质补充药物。 ...

Core Viewpoint - The company has received approval from the National Medical Products Administration for the marketing authorization of magnesium aspartate and potassium aspartate as chemical raw materials, which are essential for producing electrolyte replenishment medications [1] Group 1: Company Developments - The company's wholly-owned subsidiary, Hunan Sailong Pharmaceutical Co., Ltd., has obtained the marketing authorization approval for magnesium aspartate and potassium aspartate [1] - The approved chemical raw materials can be used to produce potassium aspartate injection and magnesium aspartate injection formulations [1] Group 2: Industry Implications - Magnesium aspartate and potassium aspartate are classified as electrolyte replenishment drugs, indicating their importance in the pharmaceutical industry for treating electrolyte imbalances [1]

Core Viewpoint - *ST Sailong (002898.SZ) has recently received approval from the National Medical Products Administration for the marketing authorization of magnesium aspartate and potassium aspartate, which are essential for producing electrolyte replenishment medications [1] Group 1 - The company’s wholly-owned subsidiary, Hunan Sailong Pharmaceutical Co., Ltd., has been granted the marketing authorization for magnesium aspartate and potassium aspartate [1] - The approved chemical raw materials can be used to produce aspartate potassium injection and aspartate magnesium injection formulations [1] - These products are classified as electrolyte replenishment drugs, indicating their importance in medical treatments [1]

Core Viewpoint - *ST Sailong (002898) announced that its wholly-owned subsidiary, Hunan Sailong Pharmaceutical Co., Ltd., has recently received approval from the National Medical Products Administration for the marketing authorization of Aspartate Magnesium and Aspartate Potassium as chemical raw materials [1] Group 1 - The approval includes the issuance of marketing authorization notification letters for both Aspartate Magnesium and Aspartate Potassium [1]